GERON CORP

Regulatory Filings • Sep 12, 2016

8-K 1 geron3126131-8k.htm CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _____

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 12, 2016

GERON CORPORATION (Exact name of registrant as specified in its charter) _____

Delaware	0-20859	75-2287752
(State or
other jurisdiction	(Commission
File Number)	(IRS
Employer
of
incorporation)		Identification
No.)

149 COMMONWEALTH DRIVE, SUITE 2070 MENLO PARK, CALIFORNIA 94025 (Address of principal executive offices, including zip code)

(650) 473-7700 (Registrant’s telephone number, including area code)

N/A (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| ☐ | Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425) |
| --- | --- |
| ☐ | Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |

Item 8.01. Other Events.

On September 12, 2016, Geron Corporation issued a press release entitled “Geron Provides Update on Imetelstat Trials Being Conducted by Janssen.” A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

| Exhibit
No. | Description |
| --- | --- |
| 99.1 | Press release dated September 12, 2016,
entitled “Geron Provides Update on Imetelstat Trials Being Conducted by
Janssen.” |

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| GERON
CORPORATION — By: | /s/ Stephen N. Rosenfield |
| --- | --- |
| Name: | Stephen N.
Rosenfield |
| Title: | Executive
Vice President, |
| | General
Counsel and |
| | Corporate
Secretary |

3

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press release dated September 12, 2016,
entitled “Geron Provides Update on Imetelstat Trials Being Conducted by
Janssen.”